Tranquility Partners, LLC Bristol Myers Squibb CO Transaction History

Tranquility Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 17, 2023	BUY	$63.71 - $70.74 $1,401 - $1,556	22 Added 0.68%	3,241 $207,000
Q1 2023 May 08, 2023	SELL	$65.71 - $74.53 $394 - $447	-6 Reduced 0.19%	3,219 $223,000
Q4 2022 Feb 02, 2023	SELL	$68.48 - $81.09 $20,544 - $24,327	-300 Reduced 8.51%	3,225 $232,000
Q2 2022 Aug 01, 2022	SELL	$72.62 - $79.98 $21,786 - $23,994	-300 Reduced 7.84%	3,525 $271,000
Q1 2022 Apr 29, 2022	BUY	$61.48 - $73.72 $24,530 - $29,414	399 Added 11.65%	3,825 $279,000
Q4 2021 Jan 31, 2022	SELL	$53.63 - $62.52 $5,523 - $6,439	-103 Reduced 2.92%	3,426 $214,000
Q3 2021 Oct 20, 2021	BUY	$59.17 - $69.31 $208,810 - $244,594	3,529 New	3,529 $209,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Tranquility Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Tranquility Partners, LLC with notifications on news.